CClinicalTrials.gg
WithdrawnNCT03141736Updated Dec 16, 2025

Kangaroo Mother Care With Plastic Bag (Trials 1A & 1B)

An interventional study of KMC & WHO protocol (0-1 hour) and KMC, WHO protocol & bag (0-1 hour) in Preterm Birth and Hypothermia, Newborn, sponsored by University of Alabama at Birmingham. Withdrawn. Open to participants aged 10 Minutes to 2 Hours. Per ClinicalTrials.gov, last updated 2025-12-16.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Prevention

Why this study was withdrawn
Staff not available to commence study.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
10 Minutes to 2 Hours
Sex
All
01

Study summary

The purpose of this study is to determine whether the combination of Kangaroo Mother Care (KMC) as continuously as possible together with the use of a plastic bag in combination with routine World Health Organization (WHO) thermoregulation care reduces the incidence of moderate (32-36° C) or severe (\<32.0° C) hypothermia in preterm infants ≥ 32 to 36 6/7 weeks of gestational age (GA) when compared to KMC as continuously as possible together with routine WHO thermoregulation care.

Read the detailed description

The purpose of this study is to determine whether the combination of Kangaroo Mother Care (KMC) as continuously as possible together with the use of a plastic bag in combination with routine World Health Organization (WHO) thermoregulation care (warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling) reduces the incidence of moderate hypothermia (32-36° C) or severe (\<32.0° C) in preterm infants ≥ 32 to 36 6/7 weeks of gestational age (GA) when compared to KMC as continuously as possible together with routine WHO thermoregulation care, as practiced.

The investigators are proposing two trials, one protocol for infants 32-36 6/7 weeks (this one) and one for infants who are ≥37 weeks gestational age. This preterm infant trial will address the effectiveness of KMC in combination with plastic bags in decreasing hypothermia in preterm infants. The proposed trial will determine whether KMC with plastic bags prevents hypothermia in neonates born in a healthcare setting with limited resources where a high risk for hypothermia has been reported. Any intervention that decreases morbidity during the neonatal period has the potential to impact health beyond the neonatal period,and one that is highly cost-effective and easy to use is more likely to be implemented in the developing world.

02

Conditions studied

  • Preterm Birth
  • Hypothermia, Newborn

Keywords

  • Infant
  • Newborn
  • Preterm
  • Hypothermia
  • Kangaroo
  • Plastic
  • Bag
03

In context

Premature Birth

2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.

Browse Premature Birth studies →

Lead sponsor

University of Alabama at Birmingham is the lead sponsor of 1,396 studies on the registry; 284 are open to participants now.

Of its 156 completed or terminated interventional studies of FDA-regulated products, 124 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Minutes to 2 Hours
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Estimated gestational age ≥32 0/7 - 36 6/7 weeks
  • Delivery in the hospital

Exclusion criteria

Exclusion Criteria:

  • Abdominal wall defect or myelomeningocele
  • Major congenital anomalies
  • Blistering skin disorder
  • Clinically unstable mothers secondary to cardiovascular and pulmonary conditions
  • Infants requiring respiratory support beyond 10 minutes after birth
  • Infant requiring NICU admission
  • C/section
  • Multiple gestation if the last delivering infant is not born within 10 minutes from the time of birth of the first infant
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Active comparator
    KMC & WHO protocol (0-1 hour)

    The combination of Kangaroo Mother Care (KMC) as continuously as possible together with routine World Health Organization (WHO) thermoregulation care (warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling.

    Other: KMC & WHO protocol (0-1 hour)

  • Active comparator
    KMC & WHO protocol (1-24 hours)

    The combination of Kangaroo Mother Care (KMC) as continuously as possible together with routine World Health Organization (WHO) thermoregulation care (warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling.

    Other: KMC & WHO protocol (1-24 hours)

  • Experimental
    KMC, WHO protocol & bag (0-1 hour)

    The combination of Kangaroo Mother Care (KMC) as continuously as possible together with the use of a plastic bag in combination with routine World Health Organization (WHO) thermoregulation care (warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling.

    Other: KMC, WHO protocol & bag (0-1 hour)

  • Experimental
    KMC, WHO protocol & bag (1-24 hours

    The combination of Kangaroo Mother Care (KMC) as continuously as possible together with the use of a plastic bag in combination with routine World Health Organization (WHO) thermoregulation care (warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling.

    Other: KMC, WHO protocol & bag (1-24 hours)

Interventions

  • OtherKMC & WHO protocol (0-1 hour)

    WHO thermoregulation care - warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling

  • OtherKMC, WHO protocol & bag (0-1 hour)

    In addition infants will be placed in a plastic bag (clear polyethylene non-medical low-cost \[3 cents per bag\]

  • OtherKMC & WHO protocol (1-24 hours)

    WHO thermoregulation care - warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling

  • OtherKMC, WHO protocol & bag (1-24 hours)

    In addition infants will be placed in a plastic bag (clear polyethylene non-medical low-cost \[3 cents per bag\]

06

What researchers measure

Primary outcomes

  1. Moderate or severe hypothermia at 1 hour after birth (Phase 1A)

    Moderate (32.0-35.9C) or severe (\<32.0C) hypothermia at 1 hour after birth (via axillary temperature)

    Time frame: 1 hour after birth

  2. Moderate or severe hypothermia at 24 hours or discharge (Phase 1B)

    Moderate (32.0-35.9C) or severe (\<32.0C) hypothermia at 24 hours or discharge whichever occurs first (via axillary temperature)

    Time frame: 1 to 24 hours after birth

Secondary outcomes

  1. Any hypothermia at 1 hour after birth (Phase 1A)

    Any hypothermia (\<36.5C) at 1 hour after birth

    Time frame: 1 hour after birth

  2. Any hypothermia at 24 hours or discharge (Phase 1B)

    Any hypothermia (\<36.5C) at 24 hours or discharge, whichever occurs first

    Time frame: 1 to 24 hours or discharge

  3. Hyperthermia at 1 hour after birth (Phase 1A)

    Hyperthermia (\>38.0C) at 1 hour after birth

    Time frame: 1 hour after birth

  4. Hyperthermia at 24 hours or discharge (Phase 1B)

    Hyperthermia (\>38.0C) at 24 hours or discharge, whichever occurs first

    Time frame: 1 to 24 hours or discharge

  5. Skin rash

    Skin rash (at 1hour and before discharge)

    Time frame: 1hour to 24 hours or discharge, or whichever occurs first

  6. Neonatal Intensive Care Unit admission

    Neonatal Intensive Care Unit admission (at 1 hour and before discharge)

    Time frame: 1hour to 24 hours or discharge, or whichever occurs first

  7. Respiratory distress syndrome

    Diagnosis of respiratory distress syndrome (at 1 hour and before discharge)

    Time frame: 1hour to 24 hours or discharge, or whichever occurs first

  8. Sepsis

    Diagnosis of sepsis (at 1hour and before discharge)

    Time frame: 1hour to 24 hours or discharge, or whichever occurs first

  9. Hypotension, hypoglycemia or seizure

    Diagnosis of any of the following; hypotension, hypoglycemia or seizure (at 1hour and before discharge)

    Time frame: 1hour to 24 hours or discharge, or whichever occurs first

  10. Death

    Death (at 1hour and before discharge)

    Time frame: 1hour to 24 hours or discharge, or whichever occurs first

  11. Maternal body temperature

    Maternal body temperature in Celsius

    Time frame: At birth, at 1 hour, every four hours until 24 hours or discharge, whichever occurs first

  12. Duration of KMC and plastic bag to infant's body temperature

    Correlation analysis between duration of KMC +/- plastic bag in minutes to infant's body temperature in Celsius

    Time frame: During first 1 hour

  13. Duration of KMC and plastic bag to infant's body temperature

    Correlation analysis between duration of KMC +/- plastic bag in minutes to infant's body temperature in Celsius

    Time frame: During first 24 hours or discharge, or whichever occurs first

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03141736
Lead sponsor
University of Alabama at Birmingham
Collaborators
University Teaching Hospital, Lusaka, Zambia
Responsible party
Colm Travers (MD, University of Alabama at Birmingham) — Principal investigator
First posted
May 5, 2017
Start date
Nov 19, 2024 (estimated)
Primary completion
Oct 12, 2025 (estimated)
Completion
Oct 12, 2025 (estimated)
Last update
Dec 16, 2025

Study contacts

Colm P Travers, MD
principal investigator · University of Alabama at Birmingham
Waldemar A Carlo, MD
study director · University of Alabama at Birmingham

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion